WallStreetZenWallStreetZen

NASDAQ: CERO
Cero Therapeutics Holdings Inc Stock

$1.78-0.09 (-4.81%)
Updated Apr 12, 2024
CERO Price
$1.78
Fair Value Price
N/A
Market Cap
$26.21M
52 Week Low
$1.55
52 Week High
$12.80
P/E
-4.56x
P/B
-1.85x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$2.54M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.01
Operating Cash Flow
-$2M
Beta
-0.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CERO Overview

Phoenix Biotech Acquisition Corp. is a "blank check" company formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It targets the healthcare and healthcare-related sectors in the U.S. and Europe. Phoenix Biotech Acquisition was incorporated in 2021 and is headquartered in Oakland, CA.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CERO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CERO is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CERO is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
CERO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more CERO due diligence checks available for Premium users.

Be the first to know about important CERO news, forecast changes, insider trades & much more!

CERO News

Valuation

CERO fair value

Fair Value of CERO stock based on Discounted Cash Flow (DCF)
Price
$1.78
Fair Value
$11.05
Undervalued by
83.89%
CERO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CERO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-4.56x
Industry
14.72x
Market
42.64x

CERO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-1.85x
Industry
5.93x

CERO's financial health

Profit margin

Revenue
$0.0
Net Income
$3.5M
Profit Margin
0%
CERO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$8.6M
Liabilities
$14.3M
Debt to equity
-1.01
CERO's short-term assets ($8.56M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CERO's long-term liabilities ($9.15M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CERO's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CERO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$3.3M
Investing
-$7.9M
Financing
-$33.1M
CERO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CERO vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
CERO$26.21M-4.81%-4.56x-1.85x
NKGN$26.27M-6.25%-0.24x-0.65x
FBRX$26.31M+0.42%-0.72x0.75x
SNSE$26.32M-3.67%-0.86x0.41x
ITRM$25.95M-3.66%-0.53x-4.05x

Cero Therapeutics Holdings Stock FAQ

What is Cero Therapeutics Holdings's quote symbol?

(NASDAQ: CERO) Cero Therapeutics Holdings trades on the NASDAQ under the ticker symbol CERO. Cero Therapeutics Holdings stock quotes can also be displayed as NASDAQ: CERO.

If you're new to stock investing, here's how to buy Cero Therapeutics Holdings stock.

What is the 52 week high and low for Cero Therapeutics Holdings (NASDAQ: CERO)?

(NASDAQ: CERO) Cero Therapeutics Holdings's 52-week high was $12.80, and its 52-week low was $1.55. It is currently -86.09% from its 52-week high and 14.84% from its 52-week low.

How much is Cero Therapeutics Holdings stock worth today?

(NASDAQ: CERO) Cero Therapeutics Holdings currently has 14,723,565 outstanding shares. With Cero Therapeutics Holdings stock trading at $1.78 per share, the total value of Cero Therapeutics Holdings stock (market capitalization) is $26.21M.

Cero Therapeutics Holdings stock was originally listed at a price of $10.08 in Oct 6, 2021. If you had invested in Cero Therapeutics Holdings stock at $10.08, your return over the last 2 years would have been -82.34%, for an annualized return of -57.98% (not including any dividends or dividend reinvestments).

How much is Cero Therapeutics Holdings's stock price per share?

(NASDAQ: CERO) Cero Therapeutics Holdings stock price per share is $1.78 today (as of Apr 12, 2024).

What is Cero Therapeutics Holdings's Market Cap?

(NASDAQ: CERO) Cero Therapeutics Holdings's market cap is $26.21M, as of Apr 14, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cero Therapeutics Holdings's market cap is calculated by multiplying CERO's current stock price of $1.78 by CERO's total outstanding shares of 14,723,565.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.